Evidence map›Paper›PMID 35619703›Full record

ArticleFrontiers in immunology2022

Transcriptome and TCR Repertoire Measurements of CXCR3

Chenfeng He, Michael J Malone, Ben S Wendel, Ke-Yue Ma, Daniel Del Alcazar, David B Weiner, Philip L De Jager, Perla M Del Río-Estrada, Yuria Ablanedo-Terrazas, Gustavo Reyes-Terán and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Advances in HIV Research Using Mass Cytometry.Current HIV/AIDS reports · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Chenfeng HeDepartment of Biomedical Engineering, Cockrell School of Engineering, University of Texas at Austin, Austin, TX, United States.
Michael J MaloneDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, United States.
Ben S WendelDepartment of Biomedical Engineering, Cockrell School of Engineering, University of Texas at Austin, Austin, TX, United States.
Ke-Yue MaInterdisciplinary Life Sciences Graduate Program, University of Texas at Austin, Austin, TX, United States.
Daniel Del AlcazarDepartment of Medicine, Division of Rheumatology, Perelman School of Medicine, Institute for Immunology, University of Pennsylvania, Philadelphia, PA, United States.
David B WeinerVaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA, United States.
Philip L De JagerColumbia University Medical Center, Center for Translational and Computational Neuroimmunology, New York, NY, United States.
Perla M Del Río-EstradaDepartamento de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Ciudad de México, Mexico.
Yuria Ablanedo-TerrazasDepartamento de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Ciudad de México, Mexico.
Gustavo Reyes-TeránComisión Coordinadora de Institutos Nacional de Salud y Hospitales de Alta Especialidad, Secretaría de Salud, Ciudad de México, Mexico.
Laura F SuDepartment of Medicine, Division of Rheumatology, Perelman School of Medicine, Institute for Immunology, University of Pennsylvania, Philadelphia, PA, United States.
Ning JiangDepartment of Biomedical Engineering, Cockrell School of Engineering, University of Texas at Austin, Austin, TX, United States.
The University of Texas at Austin · USInstituto Nacional de Enfermedades Respiratorias · MXPhiladelphia VA Medical Center · USUniversity of Pennsylvania · USColumbia University Irving Medical Center · USSecretaria de Salud · MXThe Wistar Institute · US

Funding

Synthetic DNA & Novel Env Vaccine for HIVU19AI109646 · NIAID · WISTAR INSTITUTE · PI WEINER, DAVID B. · 2015 to 2019
$16.7M
Defining the impact of pre-existing memory T cells in human immunityR01AI134879 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SU, LAURA · 2017 to 2021
$2.5M
An integrated approach to T cell repertoire in agingR56AG064801 · NIA · UNIVERSITY OF TEXAS AT AUSTIN · PI JIANG, NING JENNY · 2019 to 2020
$700k
BioMark HD System for High-Throughput Genomic StudiesS10OD020072 · OD · UNIVERSITY OF TEXAS AT AUSTIN · PI JIANG, NING JENNY · 2015 to 2015
$489k
NIAID NIH HHS R01 AI134879NIAID NIH HHS U19 AI109646NIA NIH HHS R56 AG064801NIH HHS S10 OD020072
6 · The paper itself

Abstract

Follicular-helper T cells (T

Indexed as

HIV InfectionsT Follicular Helper CellsAnimalsGerminal CenterHumansMiceReceptors, Antigen, T-CellReceptors, CXCR3T-Lymphocytes, Helper-InducerTranscriptomeCXCR3 protein, humanReceptors, Antigen, T-CellReceptors, CXCR3CXCR3follicular-helper T cells (TFH)HIVRNA-seqTCR repertoire

Identifiers

PMID35619703
PMCPMC9128546
OpenAlexW4229008325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.